Overseas expansion through coordination between trading company-affiliated and manufacturer-affiliated subsidiaries
First written in FY2016. 8 of 15 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-08-07.
The whole theme swung hardest in 2025: 5 of 45 companies on the "Worse" side.
1 other company's latest entry also says "Cited as achieved".
- 2026-08-07Cited as achievedFinancial results presentation
「The performance of the ODA specialist trading company that joined the group in the previous fiscal year made a new contribution」
The ODA specialist trading company that joined the group in the previous fiscal year contributed to results for the first quarter. - FY2026AdvancedAnnual report
「Specifically, in addition to preparing the second and third projects in the senior-oriented condominium business, entering overseas ODA projects and expanding the medical information solutions business,」
In addition to the existing overseas business, entry into overseas ODA projects has been identified as a specific new initiative. - FY2022RestatedAnnual report
「We will also pursue strategic overseas expansion by linking our trading company and manufacturer operations.」
The policy of overseas expansion linking trading company and manufacturer operations has been reiterated as a medium- to long-term strategy. The disclosure also notes the effects of the political upheaval, lockdowns and financial sanctions on the Myanmar business. - FY2021RestatedAnnual report
「Although the impact of worsening security conditions in the Republic of the Union of Myanmar was beginning to spread, operations generally progressed as planned.」
While overseas expansion linking trading company and manufacturer operations is continuing, the disclosure also states that the impact of worsening security conditions in Myanmar is beginning to spread. - FY2021-Q2RestatedAnnual report
「Although the results of the newly consolidated Myanmar medical equipment distribution subsidiary contributed to performance,」
The Myanmar medical equipment distribution subsidiary contributed to post-consolidation results, and overseas expansion initiatives are continuing. No new acquisition or completion milestone has been indicated. - FY2021-Q1AdvancedAnnual report
「Our group acquired the shares to further expand its business in Myanmar.」
On 27 April 2020, additional shares were acquired in the Myanmar medical equipment distributors Okkar Thiri Co.,Ltd. and Snow Everest Co.,Ltd., making both companies consolidated subsidiaries with an 80.0% voting rights ratio. Overseas expansion progressed from the existing service rollout and launch stage to the business expansion stage through the acquisition and consolidation of local distributors. - FY2020AdvancedAnnual report
「As for SHIP AICHI MEDICAL SERVICE,LTD., trial outpatient services at the existing building began in November 2019.」
Trial outpatient services at the existing building for the Bangladesh hospital business began in November 2019, and the Total Pack Produce business added 381 employees. Overseas expansion progressed from the stage of recording launch expenses to the stage of trial medical services. - FY2020-Q1RestatedAnnual report
「In the Total Pack Produce business, projects progressed steadily. At the same time, initial expenses continued to be recorded for launching the Osaka Heavy-Ion Therapy Center and the Bangladesh hospital business.」
Initiatives involving overseas and large-scale projects associated with launching the Osaka Heavy-Ion Therapy Center and the Bangladesh hospital business are continuing. No new completion milestone has been indicated. - FY2018AdvancedAnnual report
「In addition, preparations for future growth progressed as planned, including the launch of the PFI project to operate the International Legal Affairs Comprehensive Center, the start of outpatient consultations at the heavy-ion radiotherapy facility (treatment is scheduled to begin in October), and progress on hospital construction in Bangladesh.」
The construction of the Bangladesh hospital was described as progressing as planned as a specific overseas expansion project. - FY2018-Q3RestatedAnnual report
「In the Total Pack Produce business, expenses related to launching overseas subsidiaries and heavy-ion radiotherapy facilities were recorded, but projects progressed as planned, mainly large-scale projects.」
Expenses related to launching overseas subsidiaries were recorded, and initiatives related to overseas expansion are continuing. However, no new overseas base or specific completion milestone has been indicated. - FY2017-Q3AdvancedAnnual report
「As for Ship Aichi Medical Service, Ltd., it has been included in the scope of consolidation due to its increased materiality.」
The materiality of Ship Aichi Medical Service, Ltd., which is related to overseas expansion, increased, and the company became subject to consolidation. - FY2016First statedAnnual report
「We will also pursue strategic overseas expansion by linking our trading company and manufacturer operations.」
An overseas expansion policy that links subsidiaries in the trading and manufacturing businesses. The establishment of a Myanmar subsidiary and plans for overseas hospitals have also been disclosed.